Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0

被引：24

作者：

Albert, Nathalie L. ^{[1
]}

Preusser, Matthias ^{[13
]}

Traub-Weidinger, Tatjana ^{[17
,18
]}

Tolboom, Nelleke ^{[14
,15
]}

Law, Ian ^{[11
]}

Palmer, Joshua D. ^{[12
]}

Guedj, Eric ^{[5
]}

Furtner, Julia ^{[4
]}

Fraioli, Fracesco

Huang, Raymond Y. ^{[8
]}

Johnson, Derek R. ^{[10
]}

Deroose, Christophe M. ^{[3
]}

Hermann, Ken ^{[6
,7
]}

Vogelbaum, Michael ^{[24
]}

Chang, Susan ^{[2
]}

Tonn, Joerg-Christian ^{[16
]}

Weller, Michael ^{[19
,20
]}

Wen, Patrick Y. ^{[25
]}

van den Bent, Martin J. ^{[21
]}

Verger, Antoine ^{[22
,23
]}

Ivanidze, Jana ^{[9
]}

Galldiks, Norbert ^{[26
,27
,28
,29
]}

机构：

[1] Univ Hosp LMU Munich, Dept Nucl Med, Marchioninistr 15, D-81377 Munich, Germany

[2] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA

[3] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Imaging & Pathol, Nucl Med & Mol Imaging, Leuven, Belgium

[4] Danube Private Univ, Fac Med & Dent, Res Ctr Med Image Anal & Artificial Intelligence M, A-3500 Krems, Austria

[5] Aix Marseille Univ, Timone Hosp, APHM, Nucl Med Dept,Inst Fresnel,CERIMED,CNRS, Marseille, France

[6] Univ Duisburg Essen, Dept Nucl Med, Essen, Germany

[7] Univ Hosp Essen, German Canc Consortium DKTK, Essen, Germany

[8] Brigham & Womens Hosp, Dept Radiol, Boston, MA USA

[9] Weill Cornell Med, Dept Radiol, New York, NY USA

[10] Mayo Clin, Dept Radiol, Rochester, MN USA

[11] Univ Copenhagen, Dept Clin Physiol & Nucl Med, Rigshosp, Copenhagen, Denmark

[12] Ohio State Univ, Wexner Med Ctr, Dept Radiat Oncol, Columbus, OH USA

[13] Med Univ Vienna, Dept Med 1, Div Oncol, Vienna, Austria

[14] Princess Maxima Ctr Paediat Oncol, Heidelberglaan 25, NL-3584 CS Utrecht, Netherlands

[15] Univ Med Ctr Utrecht, Div Imaging & Oncol, Utrecht, Netherlands

[16] Ludwig Maximilians Univ Munchen, Dept Neurosurg, Munich, Germany

[17] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Div Nucl Med, Vienna, Austria

[18] Vienna Hlth Care Grp, Dept Diagnost & Therapeut Nucl Med, Clin Donaustadt, Vienna, Austria

[19] Univ Hosp, Dept Neurol, Zurich, Switzerland

[20] Univ Zurich, Zurich, Switzerland

[21] Univ Med Ctr Rotterdam, Brain Tumor Ctr, Dept Neurol, Erasmus MC Canc Inst, Rotterdam, Netherlands

[22] Univ Lorraine, Dept Nucl Med & Nancyclotep Imaging Platform, CHRU Nancy, Nancy, France

[23] Univ Lorraine, IADI, INSERM, UMR 1254, Nancy, France

[24] Cleveland Clin, Dept Neurosurg, Cleveland, OH USA

[25] Dana Farber Canc Inst, Ctr Neurooncol, Boston, MA USA

[26] Res Ctr Juelich, Inst Neurosci & Med INM 3, Julich, Germany

[27] Fac Med, Dept Neurol, Cologne, Germany

[28] Univ Hosp Cologne, Cologne, Germany

[29] Univ Cologne, Ctr Integrated Oncol CIO Aachen Bonn Cologne & Due, Cologne, Germany

来源：

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷 / 12期

关键词：

Meningioma; PET; Procedure guideline; Somatostatin receptor; DOTATATE; DOTATOC; SiTATE; PRRT; Targeted radionuclide therapy; Theranostics; TARGETED RADIOPEPTIDE THERAPY; ATTENUATION CORRECTION; RADIONUCLIDE THERAPY; GA-68-DOTATOC PET/CT; STEREOTACTIC RADIOTHERAPY; REFRACTORY MENINGIOMA; PET/MRI; EANM; LU-177-DOTATATE; Y-90-DOTATOC;

D O I：

10.1007/s00259-024-06783-x

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Purpose To provide practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor (SSTR) ligands.Methods This joint practice guideline/procedure standard was collaboratively developed by the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Neurooncology (EANO), and the PET task force of the Response Assessment in Neurooncology Working Group (PET/RANO).Results Positron emission tomography (PET) using somatostatin receptor (SSTR) ligands can detect meningioma tissue with high sensitivity and specificity and may provide clinically relevant information beyond that obtained from structural magnetic resonance imaging (MRI) or computed tomography (CT) imaging alone. SSTR-directed PET imaging can be particularly useful for differential diagnosis, delineation of meningioma extent, detection of osseous involvement, and the differentiation between posttherapeutic scar tissue and tumour recurrence. Moreover, SSTR-peptide receptor radionuclide therapy (PRRT) is an emerging investigational treatment approach for meningioma.Conclusion These practice guidelines will define procedure standards for the application of PET imaging in patients with meningiomas and related SSTR-targeted PRRTs in routine practice and clinical trials and will help to harmonize data acquisition and interpretation across centers, facilitate comparability of studies, and to collect larger databases. The current document provides additional information to the evidence-based recommendations from the PET/RANO Working Group regarding the utilization of PET imaging in meningiomas Galldiks (Neuro Oncol. 2017;19(12):1576-87). The information provided should be considered in the context of local conditions and regulations.

引用

页码：3662 / 3679

页数：18

共 82 条

[61] A Quantitative Evaluation of Joint Activity and Attenuation Reconstruction in TOF PET/MR Brain Imaging [J].

Rezaei, Ahmadreza ;

Schramm, Georg ;

Willekens, Stefanie M. A. ;

Delso, Gaspar ;

Van Laere, Koen ;

Nuyts, Johan .

JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (11) :1649-1655

[62] Cost-Effectiveness Analysis of 68Ga-DOTATATE PET/MRI in Radiotherapy Planning in Patients with Intermediate-Risk Meningioma [J].

Rodriguez, J. ;

Martinez, G. ;

Mahase, S. ;

Roytman, M. ;

Haghdel, A. ;

Kim, S. ;

Madera, G. ;

Magge, R. ;

Pan, P. ;

Ramakrishna, R. ;

Schwartz, T. H. ;

Pannullo, S. C. ;

Osborne, J. R. ;

Lin, E. ;

Knisely, J. P. S. ;

Sanelli, P. C. ;

Ivanidze, J. .

AMERICAN JOURNAL OF NEURORADIOLOGY, 2023, 44 (07) :783-791

[63] Somatostatin receptor-2 negative meningioma: pathologic correlation and imaging implications [J].

Roytman, Michelle ;

Pisapia, David J. ;

Liechty, Benjamin ;

Lin, Eaton ;

Skafida, Myrto ;

Magge, Rajiv S. ;

Osborne, Joseph R. ;

Pannullo, Susan C. ;

Knisely, Jonathan P. S. ;

Ramakrishna, Rohan ;

Ivanidze, Jana .

CLINICAL IMAGING, 2020, 66 :18-22

[64] Somatostatin-receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptake [J].

Seystahl, Katharina ;

Stoecklein, Veit ;

Schuller, Ulrich ;

Rushing, Elisabeth ;

Nicolas, Guillaume ;

Schafer, Niklaus ;

Ilhan, Harun ;

Pangalu, Athina ;

Weller, Michael ;

Tonn, Jorg-Christian ;

Sommerauer, Michael ;

Albert, Nathalie L. .

NEURO-ONCOLOGY, 2016, 18 (11) :1538-1547

[65] Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors [J].

Strosberg, J. ;

El-Haddad, G. ;

Wolin, E. ;

Hendifar, A. ;

Yao, J. ;

Chasen, B. ;

Mittra, E. ;

Kunz, P. L. ;

Kulke, M. H. ;

Jacene, H. ;

Bushnell, D. ;

O'Dorisio, T. M. ;

Baum, R. P. ;

Kulkarni, H. R. ;

Caplin, M. ;

Lebtahi, R. ;

Hobday, T. ;

Delpassand, E. ;

Van Cutsem, E. ;

Benson, A. ;

Srirajaskanthan, R. ;

Pavel, M. ;

Mora, J. ;

Berlin, J. ;

Grande, E. ;

Reed, N. ;

Seregni, E. ;

Oberg, K. ;

Sierra, M. Lopera ;

Santoro, P. ;

Thevenet, T. ;

Erion, J. L. ;

Ruszniewski, P. ;

Kwekkeboom, D. ;

Krenning, E. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (02) :125-135

[66] 177Lu-Dotatate plus long-acting octreotide versus high-dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial [J].

Strosberg, Jonathan R. ;

Caplin, Martyn E. ;

Kunz, Pamela L. ;

Ruszniewski, Philippe B. ;

Bodei, Lisa ;

Hendifar, Andrew ;

Mittra, Erik ;

Wolin, Edward M. ;

Yao, James C. ;

Pavel, Marianne E. ;

Grande, Enrique ;

Van Cutsem, Eric ;

Seregni, Ettore ;

Duarte, Hugo ;

Gericke, Germo ;

Bartalotta, Amy ;

Mariani, Maurizio F. ;

Demange, Arnaud ;

Mutevelic, Sakir ;

Krenning, Eric P. .

LANCET ONCOLOGY, 2021, 22 (12) :1752-1763

[67] EANM procedure guideline for radio-immunotherapy for B-cell lymphoma with 90Y-radiolabelled ibritumomab tiuxetan (Zevalin) [J].

Tennvall, Jan ;

Fischer, Manfred ;

Delaloye, Angelika Bischof ;

Bombardieri, Emilio ;

Bodei, Lisa ;

Giammarile, Francesco ;

Lassmann, Michael ;

Oyen, Wim ;

Brans, Boudewijn .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (04) :616-622

[68] Clinical evaluation of TOF versus non-TOF on PET artifacts in simultaneous PET/MR: a dual centre experience [J].

ter Voert, Edwin E. G. W. ;

Veit-Haibach, Patrick ;

Ahn, Sangtae ;

Wiesinger, Florian ;

Khalighi, M. Mehdi ;

Levin, Craig S. ;

Iagaru, Andrei H. ;

Zaharchuk, Greg ;

Huellner, Martin ;

Delso, Gaspar .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (07) :1223-1233

[69]

Treves ST, 2016, J NUCL MED, V57, p15N

[70] Simpson Grade Revisited - Intraoperative Estimation of the Extent of Resection in Meningiomas Versus Postoperative Somatostatin Receptor Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging [J].

Ueberschaer, Moritz ;

Vettermann, Franziska Jill ;

Forbrig, Robert ;

Unterrainer, Marcus ;

Siller, Sebastian ;

Biczok, Anna-Maria ;

Thorsteinsdottir, Jun ;

Cyran, Clemens C. ;

Bartenstein, Peter ;

Tonn, Joerg-Christian ;

Albert, Nathalie Lisa ;

Schichor, Christian .

NEUROSURGERY, 2021, 88 (01) :140-146

← 1 2 3 4 5 6 7 8 9 →